Comparative Pharmacology
Head-to-head clinical analysis: DURAGESIC 75 versus JOBEVNE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DURAGESIC 75 versus JOBEVNE.
DURAGESIC-75 vs JOBEVNE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fentanyl is a potent opioid agonist primarily at the mu-opioid receptor, exerting its analgesic effects by mimicking endogenous endorphins and enkephalins to activate G-protein-coupled inwardly rectifying potassium channels, leading to hyperpolarization and reduced neuronal excitability in pain pathways.
JOBEVNE is a monoclonal antibody that binds to and inhibits the activity of a specific cytokine receptor, reducing inflammatory signaling.
Adults: Apply one 75 mcg/hr transdermal patch every 72 hours. Start with lower dose in opioid-naive patients.
100 mg intravenously every 12 hours.
None Documented
None Documented
22-25 hours after removal of patch; increased in elderly, hepatic/renal impairment
Terminal half-life: 12-15 hours; clinical context: supports twice-daily dosing in most patients
Renal (75% as metabolites, <10% unchanged), fecal (25%)
Renal: 60% unchanged; biliary/fecal: 30% as metabolites; 10% other
Category C
Category C
Opioid Analgesic
Opioid Analgesic